Review
doi: 10.1182/blood.v97.5.1196.
How I treat chronic graft-versus-host disease
Affiliations
- PMID: 11222360
- DOI: 10.1182/blood.v97.5.1196
Item in Clipboard
Review
How I treat chronic graft-versus-host disease
Blood.
.
Free article
Abstract
Allogeneic stem cell transplantation (SCT) is now a commonplace procedure. Clinicians who care for patients with hematologic malignancies and aplastic anemia are almost certain to follow up patients after SCT. This review is intended to help clinicians observe patients for probably the most important late complication of SCT, chronic graft-versus-host disease (GVHD). It reviews the pathophysiology, risk factors, clinical manifestations, evaluation, treatment, and supportive care of chronic GVHD.
Comment in
-
An update on how to treat chronic GVHD.Blood. 2003 Sep 15;102(6):2312. doi: 10.1182/blood-2003-06-2064. Blood. 2003. PMID: 12959944 No abstract available.
Similar articles
-
Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation.Rev Assoc Med Bras (1992). 2016 Oct;62 Suppl 1:44-50. doi: 10.1590/1806-9282.62.suppl1.44. Rev Assoc Med Bras (1992). 2016. PMID: 27982319 Review.
-
Cutaneous manifestations of graft-versus-host disease: role of the dermatologist.Int J Dermatol. 2017 Feb;56(2):131-140. doi: 10.1111/ijd.13381. Epub 2016 Sep 23. Int J Dermatol. 2017. PMID: 27658806 Review.
-
The Pathophysiology and Treatment of Graft-Versus-Host Disease: Lessons Learnt From Animal Models.Front Immunol. 2021 Aug 19;12:715424. doi: 10.3389/fimmu.2021.715424. eCollection 2021. Front Immunol. 2021. PMID: 34489966 Free PMC article. Review.
-
Vulvovaginal Graft-Versus-Host Disease.Obstet Gynecol Clin North Am. 2017 Sep;44(3):475-492. doi: 10.1016/j.ogc.2017.05.007. Obstet Gynecol Clin North Am. 2017. PMID: 28778644 Review.
-
Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.Biol Blood Marrow Transplant. 2017 Sep;23(9):1498-1508. doi: 10.1016/j.bbmt.2017.05.026. Epub 2017 May 26. Biol Blood Marrow Transplant. 2017. PMID: 28554856
Cited by
-
Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside.ScientificWorldJournal. 2011;11:1908-31. doi: 10.1100/2011/924954. Epub 2011 Oct 25. ScientificWorldJournal. 2011. PMID: 22125447 Free PMC article. Review.
-
EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantation.Bone Marrow Transplant. 2014 Jul;49(7):927-33. doi: 10.1038/bmt.2014.80. Epub 2014 Apr 28. Bone Marrow Transplant. 2014. PMID: 24777191
-
Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.Cochrane Database Syst Rev. 2022 Jun 9;6(6):CD009898. doi: 10.1002/14651858.CD009898.pub4. Cochrane Database Syst Rev. 2022. PMID: 35679154 Free PMC article.
-
Group Coping Intervention in Patients With Chronic Graft-Versus-Host Disease: A Pilot Randomized Clinical Trial.J Natl Compr Canc Netw. 2024 Feb;22(1):34-42. doi: 10.6004/jnccn.2023.7080. J Natl Compr Canc Netw. 2024. PMID: 38394783 Free PMC article. Clinical Trial.
-
Immunotherapy of cancer for the elderly patient: does allogeneic bone marrow transplantation after nonmyeloablative conditioning provide a new option?Cancer Immunol Immunother. 2004 Aug;53(8):659-76. doi: 10.1007/s00262-004-0503-2. Epub 2004 Apr 6. Cancer Immunol Immunother. 2004. PMID: 15067430 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
